Drug Profile
Epoetin alfa biosimilar - Sedico
Alternative Names: Epoetin 2000 I.U. Sedico; Epoetin 4000 I.U. SedicoLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Sedico
- Class Antianaemics; Recombinant erythropoietins
- Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaemia; Chemotherapy-induced anaemia
Most Recent Events
- 28 Feb 2014 Launched prior to 2014 for Chemotherapy-induced anaemia in Egypt (IV)
- 28 Feb 2014 Launched prior to 2014 for Chemotherapy-induced anaemia in Egypt (SC)
- 28 Feb 2014 Launched prior to 2014 for Anaemia in Egypt (IV)